Holen Sie sich die Stockscreener-App
88.26
1.26%
1.10
Handel nachbörslich:
89.21
0.95
+1.08%
Schlusskurs vom Vortag:
$87.16
Offen:
$87.65
24-Stunden-Volumen:
1.74M
Relative Volume:
1.23
Marktkapitalisierung:
$10.05B
Einnahmen:
$13.38B
Nettoeinkommen (Verlust:
$418.00M
KGV:
26.65
EPS:
3.3112
Netto-Cashflow:
$391.00M
1W Leistung:
+5.25%
1M Leistung:
+8.68%
6M Leistung:
+10.35%
1J Leistung:
+27.32%
1-Tages-Spanne:
$87.50
$89.34
1-Wochen-Bereich:
$83.70
$89.34
52-Wochen-Spanne:
$61.95
$89.34
Henry Schein Inc Stock (HSIC) Company Profile
Firmenname
Henry Schein Inc
Sektor
Branche
Telefon
(631) 843-5500
Adresse
135 DURYEA RD, MELVILLE, NY
Compare HSIC vs MCK, COR, CAH, AHG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
88.26 | 9.93B | 13.38B | 418.00M | 391.00M | 3.3112 |
MCK
Mckesson Corp
|
841.31 | 93.23B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
307.99 | 57.70B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
228.72 | 52.68B | 250.74B | 1.55B | 4.39B | 6.5398 |
AHG
Akso Health Group Adr
|
1.56 | 1.31B | 14.85M | -136.07M | 7.25M | -0.4726 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-16 | Eingeleitet | BTIG Research | Neutral |
| 2026-04-15 | Eingeleitet | Citigroup | Buy |
| 2026-02-23 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-08-26 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-07-25 | Herabstufung | Stifel | Buy → Hold |
| 2025-07-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-02-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-01-06 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-07-22 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-12 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-11-10 | Hochstufung | Stifel | Hold → Buy |
| 2022-08-08 | Hochstufung | UBS | Sell → Neutral |
| 2022-07-21 | Herabstufung | Goldman | Buy → Neutral |
| 2022-06-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-05-13 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Underweight |
| 2022-01-07 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-02-08 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-01-04 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-11-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-07 | Hochstufung | Goldman | Neutral → Buy |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-01-09 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-01-02 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2019-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-05-30 | Eingeleitet | Wolfe Research | Underperform |
| 2019-05-15 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-01-17 | Eingeleitet | UBS | Sell |
| 2019-01-03 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2019-01-02 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2018-11-08 | Bestätigt | Barrington Research | Outperform |
| 2018-10-25 | Herabstufung | Edward Jones | Hold → Sell |
| 2018-10-19 | Fortgesetzt | Goldman | Neutral |
| 2018-10-04 | Bestätigt | Robert W. Baird | Outperform |
| 2018-08-07 | Bestätigt | Stifel | Hold |
| 2018-04-24 | Herabstufung | Goldman | Buy → Neutral |
| 2018-04-04 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
Alle ansehen
Henry Schein Inc Aktie (HSIC) Neueste Nachrichten
Henry Schein stock hits 52-week high at 89.34 USD - Investing.com
Henry Schein stock reflects steady healthcare distribution business - Ad Hoc News
What to Expect From Henry Schein's Next Quarterly Earnings Report - inkl
Henry Schein stock holds steady as dental and medical distribution remains a core healthcare backbon - Ad Hoc News
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
Henry Schein stock reflects steady health-care distribution business - Ad Hoc News
Multi-year Support for Henry Schein Innovation Laboratory - The Medical University of South Carolina
Henry Schein Modestly Gains as Healthcare Demand Remains ResilientPercent Below MA - DonanımHaber
Is Now The Time To Look At Buying Henry Schein, Inc. (NASDAQ:HSIC)? - Moomoo
BMO Capital Maintains Henry Schein(HSIC.US) With Hold Rating, Raises Target Price to $85 - Moomoo
Henry Schein (HSIC) Q1 2026 Earnings Call Transcript - Fortune
Henry Schein stock stays supported by steady dental demand - AD HOC NEWS
Is Henry Schein Inc (HSIC) a Bargain After 4.2% Drop? GF Value S - GuruFocus
Henry Schein (HSIC) Coverage Initiated by BMO Capital with Marke - GuruFocus
Henry Schein Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Henry Schein focuses on dental and medical distribution as investors watch sector trends - Ad-hoc-news.de
Evercore ISI Adjusts Price Target on Henry Schein to $100 From $90 - Moomoo
Henry Schein Inc focuses on dental and medical supply distribution as investors watch long term fund - ad-hoc-news.de
Piper Sandler reiterates Henry Schein stock rating on dental market view - Investing.com Nigeria
Is Henry Schein (HSIC) Stock Undervalued Right Now? - Yahoo Finance
Henry Schein (HSIC) Could Be 2% Undervalued Following GoTu Partnership - Sahm
Henry Schein stock keeps the focus on guidance and operations. - ad-hoc-news.de
smartIPR Now Available from Henry Schein Orthodontics - Dentistry Today
Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Growth in the Medical Distribution Sector with a 1.89% Upside - DirectorsTalk Interviews
Henry Schein (HSIC) price target increased by 12.37% to 90.80 - MSN
Henry Schein (HSIC) Stifel Jaws & Paws Conference 2026 Summary - Quartr
Henry Schein Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Should Henry Schein’s (HSIC) GoTu Partnership Reshape Its Efficiency-Focused Dental Staffing Strategy? - Sahm
Dentrix dental practice software from Henry Scheincloud tools for busy US clinics - AD HOC NEWS
Henry Schein focuses on dental and medical supplies as a diversified health-care distributor - AD HOC NEWS
List of 35 Acquisitions by Henry Schein (Jul 2026) - Tracxn
Henry Schein Maxima Pro 2 Cartridge from Henry Scheinprecision dental composite for everyday rest - AD HOC NEWS
Form 144 HENRY SCHEIN INC For: 30 June - Investing.com UK
GoTu and Henry Schein Partner to Address Dental Staffing Shortages - geneonline.com
GoTu Technology And Henry Schein, Inc. Announce Strategic Partnership To Strengthen Dental Workforce Support Nationwide - marketscreener.com
Form 144 HENRY SCHEIN INC For: 30 June By Investing.com - Investing.com Nigeria
GoTu partners with Henry Schein on dental staffing platform By Investing.com - Investing.com Nigeria
HSIC (NASDAQ) Form 144 — Fidelity lists 28,791 shares, $2.43M value - Stock Titan
GoTu partners with Henry Schein on dental staffing platform - Investing.com
GoTu and Henry Schein Announce Strategic Partnership to Strengthen Dental Workforce Support Nationwide - PR Newswire
Henry Schein stock draws fresh interest after Russell 1000 change. Earnings growth and guidance fram - AD HOC NEWS
Henry Schein consensus picture on Wall Street, shares in steady NASDAQ trade - AD HOC NEWS
Henry Schein stock: Is Wall Street bullish or bearish? - MSN
Henry Schein exits a key Russell index, shares face sector comparison in the S&P 500 - AD HOC NEWS
Henry Schein, Inc.(NasdaqGS: HSIC) dropped from Russell 1000 Dynamic Index - marketscreener.com
Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Growth With A 3.67% Potential Upside - DirectorsTalk Interviews
The Cavitron Touch Ultrasonic Scaling System from Henry Schein Inc.quieter control for busy hygie - AD HOC NEWS
Henry Schein focuses on long-term strategy, shares in a defensive health peer group - AD HOC NEWS
Dentrix Ascend from Henry Schein Inc.cloud software brings dental teams into one screen - Ad-hoc-news.de
Is Henry Schein stock underperforming the Nasdaq? - MSN
Henry Schein Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Finanzdaten der Henry Schein Inc-Aktie (HSIC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.96%
0.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):